Sign inGet started

Dubin Glenn

Insider CIK 1308597 · NONE 10% owner · CCCC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CCCC C4 Therapeutics, Inc. A Award2024-04-012024-04-021,358$8.10 $11.0K22,075SEC↗
CCCC C4 Therapeutics, Inc. A Award2024-01-022024-01-031,687$6.52 $11.0K20,717SEC↗
CCCC C4 Therapeutics, Inc. A Award2023-10-022023-10-036,470$1.70 $11.0K19,030SEC↗
CCCC C4 Therapeutics, Inc. A Award2023-07-032023-07-053,887$2.83 $11.0K12,560SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2023-06-152023-06-1626,000— $026,000SEC↗
CCCC C4 Therapeutics, Inc. A Award2023-04-032023-04-043,438$3.20 $11.0K8,673SEC↗
CCCC C4 Therapeutics, Inc. A Award2023-01-032023-01-041,725$6.38 $11.0K5,235SEC↗
CCCC C4 Therapeutics, Inc. A Award2022-10-032022-10-041,265$8.69 $11.0K3,510SEC↗
CCCC C4 Therapeutics, Inc. A Award2022-07-012022-07-051,372$8.03 $11.0K2,245SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2022-06-222022-06-2323,500— $023,500SEC↗
CCCC C4 Therapeutics, Inc. A Award2022-04-042022-04-05379$26.46 $10.0K873SEC↗
CCCC C4 Therapeutics, Inc. A Award2022-01-042022-01-18199$31.58 $6.3K494SEC↗
CCCC C4 Therapeutics, Inc. A Award2021-10-042021-10-05138$44.99 $6.2K295SEC↗
CCCC C4 Therapeutics, Inc. A Award2021-07-022021-08-20157$39.72 $6.2K157SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2021-03-122021-03-1641,200— $041,200SEC↗
NONE ASGI Corbin Multi-Strategy S Sale2012-06-302012-07-0220,785$102.67 $2.13M0SEC↗
NONE ASGI Corbin Multi-Strategy S Sale2012-03-302012-04-0224,542$101.18 $2.48M20,428SEC↗
NONE ASGI Corbin Multi-Strategy S Sale2011-12-312012-01-0363,585$99.63 $6.33M44,766SEC↗